Kevin Winthrop
Clinical trials sponsored by Kevin Winthrop, explained in plain language.
-
New hope for rare lung infection: drug trial targets stubborn bacteria
Disease control Recruiting nowThis study tests an experimental drug called epetraborole for people with a hard-to-treat lung infection caused by Mycobacterium abscessus. About 84 adults with mild to moderate disease will take the drug or a placebo daily for 84 days. Researchers will check if symptoms improve …
Phase: PHASE2 • Sponsor: Kevin Winthrop • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New drug aims to stop hearing loss from lifesaving antibiotics
Prevention Recruiting nowThis study tests a new drug, ORC-13661, to see if it can prevent hearing loss in people receiving a strong antibiotic (amikacin) for a lung infection called NTM. About 105 adults will take either a low dose, high dose, or a placebo pill daily for up to 90 days. Researchers will c…
Phase: PHASE2 • Sponsor: Kevin Winthrop • Aim: Prevention
Last updated May 15, 2026 11:57 UTC